Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 [Yahoo! Finance]
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
The assays for CMV, EBV, and BKV launched with the MyGenius PRO® under IVDR MUNICH, April 17, 2026 BUSINESS WIRE )--At ESCMID Global 2026 , the Bruker Microbiology & Infection Diagnostics division ( Bruker Corporation , Nasdaq: BRKR) announces the European launch of MyGenius PRO ® , a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for infectious disease diagnostics, the new S2A system enables higher throughput, continuous loading of samples, consumables, and reagents, and supports random-access operation. Like the successful medium-throughput BeGenius ® system, which excels at assay and sample matrix flexibility, the new higher-throughput MyGenius PRO ® automates the entire workflow - from patient sample to diagnostic result - enhancing laboratory efficiency and supporting higher-throughput volume testing needs. At launch, the MyGenius PRO ® IVDR menu will include assays for Cytomegalovirus (CMV)
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026Business Wire
- Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak ManagementBusiness Wire
- Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026Business Wire
- Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
- Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026Business Wire
BRKR
Earnings
- 2/12/26 - Miss
BRKR
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form 144
- 4/10/26 - Form ARS
- BRKR's page on the SEC website